论文部分内容阅读
[目的]观察丹红注射液联合低分子肝素钙治疗脑梗塞疗效。[方法]将122例随机分为两组。对照组61例洛伐他汀、阿司匹林等常规治疗加用丹红注射液,治疗组61例丹红注射液联合低分子肝素钙。监测凝血酶原时间、血小板计数、肝、肾功能及心电图,以及神经功能缺损评分变化。治疗14d进行疗效判定。[结果]治疗组总有效率91.80%,显效率83.6%;对照组总有效率70.49%,显效率44.3%。治疗组优于对照组(P<0.05),两组治疗后14d神经功能缺损评分较治疗前均明显降低(P<0.05),且治疗组优于对照组(P<0.05)。[结论]丹红注射液联合低分子肝素钙治疗脑梗塞安全有效。
[Objective] To observe the curative effect of Danhong injection combined with low molecular weight heparin on cerebral infarction. [Methods] 122 cases were randomly divided into two groups. In the control group, 61 cases of lovastatin, aspirin and other conventional treatment plus Danhong injection, the treatment group, 61 cases of Danhong injection combined with low molecular weight heparin. Prothrombin time, platelet count, liver and kidney function and electrocardiogram, and changes in neurological deficit scores were monitored. Treatment for 14d to determine the efficacy. [Results] The total effective rate was 91.80% in treatment group, markedly effective rate was 83.6%. The total effective rate in control group was 70.49%, and the effective rate was 44.3%. The treatment group was better than the control group (P <0.05). The neurological deficit score of the 14th day after treatment in both groups was significantly lower than that before treatment (P <0.05), and the treatment group was superior to the control group (P <0.05). [Conclusion] Danhong injection combined with low molecular weight heparin calcium is safe and effective in treating cerebral infarction.